INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M605. A total of 16 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tower Research Capital LLC (TRC) | 7,391 | $9,978 | 0.00% |
Renaissance Technologies | 17,266 | $23 | 0.00% |
TD Waterhouse Canada Inc. | 6 | $11 | 0.00% |
Allworth Financial LP | 1 | $2 | 0.00% |
VANGUARD GROUP INC | 26,246 | $35,432 | 0.00% |
Colonial Trust Advisors | 2 | $3 | 0.00% |
UBS Group AG | 1 | $1 | 0.00% |
WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
Sugarloaf Wealth Management, LLC | 1 | $1 | 0.00% |
OSAIC HOLDINGS, INC. | 7 | $8 | 0.00% |